AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 279: R1334-R1340, 2000;
0363-6119/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thresher, J. S.
Right arrow Articles by Pagliassotti, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thresher, J. S.
Right arrow Articles by Pagliassotti, M. J.
Vol. 279, Issue 4, R1334-R1340, October 2000

Comparison of the effects of sucrose and fructose on insulin action and glucose tolerance

Jeffrey S. Thresher1,2, Deborah A. Podolin3, Yuren Wei3, Robert S. Mazzeo1, and Michael J. Pagliassotti2,3

3 Department of Pediatrics, University of Colorado Health Sciences Center, Denver 80262, 1 Department of Kinesiology, University of Colorado at Boulder, Boulder, Colorado 80302; and 2 Exercise and Sport Research Institute, Arizona State University, Tempe, Arizona 85287-0404


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The purpose of the present study was to determine whether fructose is the nutrient mediator of sucrose-induced insulin resistance and glucose intolerance. Toward this end, male rats were fed a purified starch diet (68% of total calories) for a 2-wk baseline period. After this, rats either remained on the starch (ST) diet or were switched to a sucrose (SU, 68% of total calories), fructose/glucose (F/G, 34/34% of total calories), or fructose/starch (F/ST, 34/34% of total calories) diet for 5 wk. Rats then underwent either an intravenous glucose tolerance test (n = 10/diet) or a euglycemic, hyperinsulinemic clamp (n = 8 or 9/diet). Incremental glucose and insulin areas under the curve in SU, F/G, and F/ST were on average 61 and 29% greater than ST, respectively, but not significantly different from one another. During clamps, glucose infusion rates (mg · kg-1 · min-1) required to maintain euglycemia were significantly lower (P < 0.05) in SU, F/G, and F/ST (13.4 ± 0.9, 9.5 ± 1.7, 11.3 ± 1.3, respectively) compared with ST (22.8 ± 1.1). Insulin suppression of glucose appearance (mg · kg-1 · min-1) was significantly lower (P < 0.05) in SU, F/G, and F/ST (5.6 ± 0.5, 2.2 ± 1.2, and 6.6 ± 0.7, respectively) compared with ST (9.6 ± 0.4). Insulin-stimulated glucose disappearance (mg · kg-1 · min-1) was significantly lower (P < 0.05) in SU, F/G, and F/ST (17.9 ± 0.6, 16.2 ± 1.3, 15.3 ± 1.8, respectively) compared with ST (24.7 ± 1.2). These data suggest that fructose is the primary nutrient mediator of sucrose-induced insulin resistance and glucose intolerance.

diet composition


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

INSULIN RESISTANCE (reduced insulin suppression of hepatic glucose production and reduced insulin stimulation of glucose uptake) is a characteristic feature of type 2 diabetes. The development of insulin resistance can be linked to both genetic and environmental factors (8). A key environmental factor in the development of insulin resistance and the focus of this study is diet composition. Diet-induced insulin resistance is characterized by fasting normoglycemia accompanied by hyperinsulinemia, impaired insulin suppression of hepatic glucose production, and impaired insulin-stimulated glucose uptake in muscle and adipose tissue (13, 19, 20).

High-sucrose diets have been shown to impair insulin action in rats at both the hepatic and peripheral levels (13, 16, 19). During absorption, sucrose is hydrolyzed into equal quantities of fructose and glucose. Consequently, high-fructose diets have been directly compared with high-glucose or -starch diets in an attempt to distinguish which moiety of the sucrose disaccharide may be a factor in sucrose-induced insulin resistance in rats (20, 21). For example, Thorburn et al. (20) showed that a diet containing 35% fructose produced insulin resistance, whereas a diet containing 35% glucose did not. Studies such as these have led to the conclusion that fructose is responsible for sucrose-induced insulin resistance.

However, there is reason to believe that the degree of insulin resistance produced by fructose may be less than that from sucrose. Storlien et al. (19) fed male rats either a high-sucrose (69% sucrose) or high-starch (69% starch) diet for 4 wk. This study demonstrated that impaired insulin suppression of glucose production in the sucrose-fed animals was responsible for 64% of the difference seen in the glucose infusion rate between the sucrose- and starch-fed animals. In contrast, the aforementioned study by Thorburn et al. (20) demonstrated that impaired insulin suppression of glucose production in the fructose-fed animals was responsible for only 44% of the difference seen in the glucose infusion rate between the fructose- and starch-fed animals. These data suggest that the relative contributions of hepatic and peripheral insulin resistance may be different between sucrose- and fructose-containing diets. These discrepancies in no way detract from the validity of these studies but do illustrate the need for a single study that compares the effects of sucrose, fructose and glucose, and fructose and starch on hepatic and peripheral insulin action.

Impaired glucose tolerance is a risk factor for the development of type 2 diabetes. Furthermore, impaired glucose tolerance has been observed in rats fed a high-sucrose diet for 90-120 days (11). It is not clear from the literature whether the impaired glucose tolerance results from the metabolism of fructose alone or the combined effects of both fructose and glucose.

Therefore, the specific aims of the present study were 1) to compare the effects of dietary sucrose, fructose and glucose, and fructose and starch on whole body insulin action and 2) to study the effects of diet-induced insulin resistance on glucose tolerance. To achieve these aims, the euglycemic-hyperinsulinemic clamp technique was used to assess whole body insulin action and an intravenous glucose tolerance test was used to assess glucose tolerance.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Animals and Housing

Male Crl:(WI)BR rats (Sasco, Madison, WI) weighing 140-160 g were used in all experiments. The animals were individually housed in a thermally controlled environment with a 12:12-h light-dark cycle. These conditions, as well as the treatment of the animals, met guidelines set by the American Association of Laboratory Animal Care and all protocols were approved by the University of Colorado Health Sciences Center Animal Care Committee.

Diet Protocol

All animals were fed ad libitum a purified high-starch diet (ST: 68% corn starch, 12% fat, 20% protein; Table 1, Research Diets, New Brunswick, NJ) for a baseline period of 2 wk. After the baseline period, the rats were randomly assigned to either a control group (ST) or one of three dietary groups. The control group continued to be fed the ST diet for an additional 5-wk study period. The dietary groups were fed either a high-sucrose (SU: 68% sucrose, 12% fat, 20% protein), a 34% fructose, 34% glucose, 12% fat, and 20% protein (F/G), or 34% fructose, 34% starch, 12% fat, and 20% protein (F/ST) diet (Table 1) for an additional 5-wk study period. The F/G diet was chosen to test if both products of sucrose absorption (i.e., fructose and glucose) are required to produce an insulin-resistant state comparable to that of sucrose. The F/ST diet was chosen to test whether fructose alone would result in an insulin-resistant state similar to that caused by the SU diet. Starch was used instead of glucose in F/ST diet because starch is absorbed more slowly than glucose (7). Moreover, when starch is provided as the sole carbohydrate source, insulin action on glucose metabolism is not impaired (14, 16). Food intake was measured three times per week and body weight was measured once a week throughout the baseline and 5-wk dietary period.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Diet composition

Surgical Procedures

After the 5-wk dietary period, rats from each group were randomly assigned to undergo either an intravenous glucose tolerance test (IVGTT, n = 40) or a euglycemic, hyperinsulinemic clamp (n = 35). In preparation for experiments, the animals were anesthetized (intramuscular injection of acepromazine, 5 mg/kg; xylazine, 10 mg/kg; ketamine, 50 mg/kg) and cannulas (polyethylene tubing, 0.022 in. ID, PE-50 Intramedic Clay Adams, Parsippany, NJ) were inserted into the left carotid artery and advanced to the aortic arch and into the right jugular vein and advanced to the vena cava (17). Cannulas were then sutured to their respective vessels and exteriorized out the back of the neck of the animal. The cannulas were flushed and then filled with heparinized saline and sealed. The rats were allowed 4 days to recover and were at >90% of their presurgery body weight on the day of the study. This results in animals that are healthy based on the following parameters: energy intake, normal stools, and white blood cell count. During recovery, the animals were fed their respective diets ad libitum.

Study 1: IVGTT

The IVGTT was used to assess glucose tolerance and the glucose and insulin response to a glucose injection. Animals were fasted for a 24-h period to ensure that no food was being absorbed and that liver glycogen levels were at a stable minimum (13). On the day of study, extensions were added to the catheters to allow easy access without disturbing the animal. Animals were then allowed to rest for 30 min. A baseline blood sample was then taken. A glucose bolus of 0.4 g/kg body wt was injected into the venous catheter over the course of 1 min. Blood samples were taken at the following times after administration of the bolus: 5, 12.5, 20, 27.5, 35, 50, 65, and 80 min. Blood sample volumes were 250 µl, except for the 0, 20, 50, and 80 min times where they were 400 µl. This sampling protocol resulted in the removal of approx 8.9% of the animal's blood volume (assumes blood volume = 8% of body wt). Blood samples were immediately centrifuged, and plasma was analyzed for glucose on the day of the study. Plasma for insulin (all times) and triglyceride (0 min time point) analyses was frozen at -70°C. After 80 min, the animal was anesthetized with pentobarbital sodium (70 mg/kg iv). Retroperitoneal, mesenteric, and epididymal fat pads were removed and weighed. The sum of these fat pads correlates with total carcass lipid (r = 0.93, P < 0.001) (M. J. Pagliassotti and E. C. Gayles, unpublished data). In addition, urine samples were taken and immediately analyzed for glucose to monitor renal spillage of glucose during the IVGTT.

Study 2: Euglycemic, Hyperinsulinemic Clamps

The euglycemic, hyperinsulinemic clamp procedure was used to determine the magnitude and tissue distribution of insulin action. The clamp protocol included both a basal (no exogenous insulin) and hyperinsulinemic (4× basal insulin infusion) period that enabled each rat to serve as its own control. Rats were fasted for 6-8 h to ensure that animals were in a postabsorptive state but with significant amounts of liver glycogen still available (13). As in the IVGTT, extensions were added to the catheters and the animal was allowed to rest for 30 min. A baseline blood sample (300 µl) was taken, and a primed, continuous infusion of HPLC-purified [3-3H]glucose (prime of 12 µCi, infusion of 0.1 µCi/min) was initiated. Arterial blood samples (300 µl) were taken at 45, 52.5, and 60 min. After the final basal sample, an insulin infusion was initiated (4 mU · kg-1 · min-1) to elicit an approximate fourfold increase in the systemic insulin concentration (15). A variable exogenous glucose infusion (10% dextrose) was then started to clamp glucose at basal levels. The glucose infusate was spiked with [3-3H]glucose to give a specific activity in the infusate that was 50% of that expected in the plasma during the final 15 min of the basal period (45-60 min). The specific activity of the glucose infusate was chosen to account for the reduction in glucose rate of appearance due to hyperinsulinemia (1). This procedure minimized changes in glucose specific activity and allowed for accurate estimates of glucose kinetics (6). During the clamp, arterial blood samples (25 µl) were taken at 5-min intervals for immediate glucose analysis. Manual adjustments to the glucose infusion rate were then made to maintain euglycemia throughout the clamp. During the final 15-min steady-state period, larger arterial samples (300 µl) were taken (120, 127.5, and 135 min). This sampling protocol resulted in the removal of approx 12% of the animal's blood volume. All blood samples were immediately centrifuged, and the plasma was used to determine glucose concentration. Plasma from the basal steady-state period and the clamp steady-state period were used to determine glucose radioactivity and insulin concentration. After the final sample, animals were anesthetized (70 mg/kg iv pentobarbital sodium) and the entire gastrocnemius, soleus, and vastus lateralis muscles from the right hindquarter and a portion of the abdominal wall muscle were removed and immediately frozen in liquid nitrogen. These tissues were analyzed for glycogen and tracer content. Epididymal, retroperitoneal, and mesenteric fat pads were removed and weighed.

Analytic Methods

Plasma samples for tracer analysis were deproteinized overnight with ZnSO4 and Ba(OH)2. The samples were then centrifuged, dried to eliminate tritiated water, reconstituted with distilled H20, and counted in a liquid scintillation counter (Beckman Instruments, Fullerton, CA). A Beckman glucose analyzer was used to determine the plasma glucose concentration. Plasma triglycerides were measured with Sigma kit 320-A (St. Louis, MO). Plasma insulin was determined by radioimmunoassay (Linco Research, St. Charles, MO). Muscle glycogen concentration and glycogen radioactivity were measured on homogenates from the entire amount of tissue removed at the time of death according to the procedures of Chan and Exton (2). Tissue triglycerides were determined after extraction (4), and hydrolysis was determined by enzymatic assay as described above (Sigma).

Calculations

IVGTT. Insulin and glucose areas under the curve (AUC) were measured using the trapezoid rule. Only positive excursions from the baseline were included in the calculations.

Euglycemic, hyperinsulinemic clamps. During the baseline period, rates of glucose appearance (Ra) and disappearance (Rd) were estimated by isotope dilution using a constant infusion of HPLC-purified D-[3-3H]glucose (3). Steady-state equations were used because the glucose specific activity changed <0.1%/min during the sampling period. During the clamp, Ra and Rd were estimated based on the procedures of Finegood and Bergman (5).

Glycogen synthetic rate. Glycogen synthetic rate was calculated as the ratio of the average amount of [3H]glycogen (dpm/g tissue) in soleus, gastrocnemius, vastus lateralis, and abdominal muscles to the steady-state glucose specific activity. This value was divided by the length of the clamp period in minutes and multiplied by 1,000 to convert grams to kilograms. These data were used as a measure of insulin-stimulated glycogen synthesis in muscle tissue. Previous data demonstrated that negligible incorporation of [3-3H]glucose into muscle glycogen occurs under basal conditions (15).

Statistics

Analysis of variance was used to compare the following endpoints among groups: body weight, energy intake, fat pad weight, circulating metabolites (except glucose, see below) and hormones, AUC, and clamp data. Statistical significance was accepted at P < 0.05. Where appropriate, the Student-Newman-Keuls test was used for post hoc analysis. SE was calculated using an approximation when groups were of unequal size (22). Plasma glucose data was characterized by unequal variances. To compare differences among groups for this parameter, the Kruskal-Wallis statistic was used. Data are presented as means ± SE.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Study 1: IVGTT

Body weight and energy intake. Body weight (pooled mean = 213.1 ± 1.3 g) at the start of the 5-wk dietary period and energy intake (pooled mean = 2,835.7 ± 36.7 kcal) during the 5-wk period were not significantly different among groups. Weight gain during the 5-wk dietary period was significantly less in F/G (164.0 ± 10.0 g) compared with ST (199.2 ± 11.6 g) and F/ST (197.6 ± 9.6 g) but was not significantly different from SU (177.0 ± 4.8 g). There were no significant differences in fat pad mass among groups (data not shown).

Fasting glucose, insulin, and triglycerides. Fasting plasma glucose levels were not significantly different among groups. Fasting plasma insulin and triglyceride levels were significantly higher in SU, F/G, and F/ST compared with ST. Fasting plasma triglycerides were significantly higher in F/ST compared with SU and F/G (Table 2).

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Fasting plasma glucose, insulin, and triglyceride levels before IVGTT

Glucose and insulin response to IVGTT. The incremental area under the glucose curve (GAUC) was significantly greater in SU, F/G, F/ST compared with ST. The incremental area under the insulin curve (IAUC) was significantly greater in SU compared with ST. IAUC was not significantly different among ST, F/G, and F/ST. A total of 21 rats (ST, n = 1; SU, n = 6; F/G, n = 7; F/ST, n = 7) did not return to baseline glucose levels after the 80-min IVGTT period. There were no significant differences in urinary glucose among groups and urinary glucose represented <= 0.01% of the glucose bolus given during the IVGTT (Figs. 1 and 2).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   Plot of plasma glucose (mg/dl) across time for starch (ST)-, sucrose (SU)-, fructose/glucose (F/G)-, and F/ST-fed rats in response to a glucose bolus of 0.4 g/kg body wt injected intravenously. Values are means ± SE for 10 rats/group. Inset: glucose incremental area under the curve. Values are means ± SE for 10 rats/group. * Significantly different from ST-fed animals (P < 0.05).



View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   Plot of plasma insulin (µU/ml) across time for ST-, SU-, F/G-, and F/ST-fed rats in response to a glucose bolus of 0.4 g/kg body wt injected intravenously. Values are means ± SE for 10 rats/group. Inset: insulin incremental area under the curve. Values are means ± SE for 10 rats/group. * Significantly different from ST-fed animals (P < 0.05).

Study 2: Hyperinsulinemic, Euglycemic Clamps

Body weight and energy intake. Body weight (pooled mean = 230.1 ± 0.4 g) at the start of the 5-wk dietary protocol and weight gain (pooled mean = 191.7 ± 0.7 g) during the 5-wk period were not significantly different among groups. Total energy intake during the 5-wk dietary period in F/G (2,740.5 ± 92.4 kcal) and F/ST (2,846.4 ± 128.9 kcal) was significantly higher compared with SU (2,409.1 ± 69.5 kcal). The weight of the epididymal fat pad and the sum weight of epididymal, retroperitoneal, and mesenteric fat pads was significantly higher in F/ST compared with SU (Table 3).

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Clamp fat pad weight

Glucose and insulin data. Basal glucose, clamp glucose, and clamp insulin levels were not significantly different among groups. Basal insulin levels were significantly increased in SU, F/G, and F/ST compared with ST (Tables 4 and 5).

                              
View this table:
[in this window]
[in a new window]
 
Table 4.   Preclamp insulin, glucose, and glucose kinetics


                              
View this table:
[in this window]
[in a new window]
 
Table 5.   Clamp glucose kinetics data

Glucose kinetics and glucose infusion rate. Basal glucose Ra was not significantly different among ST, SU, and F/ST but was significantly lower in F/G compared with ST. During the clamps, endogenous glucose Ra was significantly higher in the SU, F/G, F/ST compared with ST. Endogenous glucose Ra was significantly higher in F/G compared with SU and F/ST. Insulin suppression of glucose Ra was significantly greater in ST compared with SU, F/G, and F/ST. Insulin suppression of glucose Ra was significantly lower in F/G compared with the SU and F/ST (Table 5).

Glucose Rd during the clamp in SU, F/G, and F/ST was significantly lower then ST. Glucose Rd was significantly lower in F/ST compared with SU and F/G. The glucose infusion rate (GIR) needed to maintain euglycemia was significantly lower in SU, F/G, and F/ST compared with ST. GIR was significantly lower in F/G group compared with SU.

Muscle glycogen synthesis rate and glycogen content. Glycogen concentrations were significantly lower in SU, F/G, and F/ST compared with ST for most of the muscles measured. Tracer estimated muscle glycogen synthesis was significantly lower in SU, F/G, and F/ST compared with ST (Table 6).

                              
View this table:
[in this window]
[in a new window]
 
Table 6.   Muscle glycogen content and synthetic rate

Liver triglycerides. Liver triglycerides (µmol/g) were significantly higher (P < 0.05) in SU, F/G, and F/ST (10.5 ± 0.9, 9.5 ± 1.0, 10.6 ± 1.3, respectively) compared with ST (6.0 ± 0.4 µmol/g).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In this study, IVGTT and euglycemic, hyperinsulinemic clamps were used to compare the effects of sucrose with that of fructose + starch and fructose + glucose on glucose tolerance and whole body insulin action in rats. The results indicate that diets containing high levels of sucrose, fructose and glucose, or fructose and starch significantly impair glucose tolerance as well as hepatic and peripheral insulin action. These data suggest that fructose is the primary nutrient mediator of sucrose-induced glucose intolerance and insulin resistance.

Study 1: IVGTT

Fasting insulin levels in the SU, F/G, and F/ST groups were more than double the levels seen in the ST control group. However, fasting plasma glucose levels were similar among all groups. These data suggest that whole body insulin action was reduced similarly among the three experimental diet groups.

GAUC was significantly higher in the three experimental diet groups compared with the ST control. However, it was not significantly different among the three experimental diet groups. Glucose tolerance is dependent on tissue sensitivity to insulin as well as the circulating levels of this hormone and the effectiveness of glucose to stimulate its own uptake while concomitantly suppressing hepatic glucose production (1). From the present data, it appears that diets containing high levels of sucrose or fructose in combination with glucose or starch all impair glucose tolerance. Results from the euglycemic, hyperinsulinemic clamp (discussed below) demonstrate that insulin action on glucose metabolism was impaired in all three experimental diet groups. However, recent data suggested that the impact of insulin action on glucose tolerance during an IVGTT is minimal in the 24-h-fasted rat (12). In fact, McArthur et al. (12) demonstrated that the glucose response to an IVGTT was primarily a function of glucose effectiveness. Thus the diet-induced reduction in glucose tolerance observed in the present study may involve impairments in "glucose action." Further studies are needed to quantify the independent roles of insulin action and glucose effectiveness on diet-induced glucose intolerance.

It must be noted that the present data underestimate the impairment in glucose tolerance. Twenty of the thirty animals in the experimental groups had not returned to baseline glucose levels after the 80-min IVGTT period (SU, n = 6; F/G, n = 7; F/ST, n = 7). In contrast, only 1 of 10 animals in the control group had not returned to baseline glucose levels after the 80-min IVGTT period. If the experimental period had been longer, the GAUC would have been even higher for the experimental groups.

The IAUC was higher in the experimental groups compared with the ST controls, but significantly so only in the sucrose-fed animals. However, because the insulin response was not significantly different among experimental groups it is unlikely that these diets resulted in different effects on insulin secretion and/or clearance.

Study 2: Euglycemic, Hyperinsulinemic Clamps

The GIR required to maintain euglycemia during the clamp in the SU-, F/G-, and F/ST-fed animals was significantly lower compared with the ST-fed controls. These data indicate that all three experimental diets produced whole body insulin resistance. The lower GIR was due, in part, to muscle insulin resistance, because tracer-estimated muscle glycogen synthesis was significantly lower in the experimental groups compared with starch-fed controls.

Insulin suppression of glucose Ra was significantly lower in SU, F/G, and F/ST compared with ST. Thus, in addition to effects in muscle, the three experimental diets produced hepatic insulin resistance (this assumes that the liver is the primary contributor to glucose Ra). From these data, it is evident that all three diets resulted in both hepatic and peripheral insulin resistance. More importantly, they demonstrate that the fructose moiety of sucrose, which is isolated in the F/ST diet, is the causative agent. These data are in agreement with those of Thorburn et al. (20).

The trigger that links simple sugars and the development of insulin resistance has not been identified. Elevated circulating and tissue triglycerides are often observed in diet-induced insulin resistance (14, 20). Recent work has continued to demonstrate an association between elevated triglyceride concentration and insulin resistance (9, 10). The present data also demonstrate that the three experimental diets resulted in significantly elevated circulating and liver triglyceride concentrations. Whether this elevation contributes to the development of insulin resistance or results from the insulin-resistant state remains uncertain.

There were several subtle but statistically significant differences among the three experimental groups. Basal rates of glucose Ra and insulin suppression of glucose Ra were reduced in the F/G group. Whether this reduction reflects differences in fructose and glucose that originate from the diet versus those that originate from hydrolysis of sucrose is presently unknown.

In animals used to study insulin action, energy intake in F/G and F/ST was significantly greater compared with SU. In contrast, weight gain among these groups was not significantly different. These data suggest that energy expenditure by the F/G and F/ST groups was greater than SU during the 5-wk dietary period resulting in weight gains during the 5-wk dietary period that were not significantly different from SU. The sum of the three fat pads that were weighed was significantly greater in F/ST compared with SU, although body weight after the 5-wk dietary period was not significantly different. Because fat mass can influence insulin action, this difference among the experimental groups must be considered when comparing groups and when comparing these data to other studies. It is unlikely to significantly influence the data as suggested by the results from the IVGTT where energy intake was not different among groups.

In the euglycemic, hyperinsulinemic clamp studies we chose to clamp all animals at similar glucose concentrations (on average 124-128 mg/dl). Because average preclamp glucose levels ranged from 131 to 145 mg/dl, this approach resulted in a greater average decrease in glucose concentration (preclamp minus clamp glucose) in the experimental groups compared with the starch group. This was required to ensure that glucose levels, and thus glucose's ability to mediate its own disposal, were normalized among groups. It is unlikely that this procedure would result in any perturbation (e.g., counterregulation) that could account for the observed reductions in insulin action. This is supported by the fact that in previous studies using a similar methodology, cortisol levels were not different among groups (unpublished observations).

With the use of IVGTT and euglycemic, hyperinsulinemic clamps, the present study compared the effects of high levels of dietary sucrose, fructose and glucose, and fructose and starch on glucose tolerance and whole body insulin action in rats. The results indicate that all three diets significantly impaired glucose tolerance and hepatic and peripheral insulin action. Because fructose in combination with starch was able to elicit a similar pattern and magnitude of insulin resistance and glucose intolerance to that of sucrose and fructose and glucose, these data indicate that fructose is the primary mediator of sucrose-induced insulin resistance and glucose intolerance.


    ACKNOWLEDGEMENTS

We acknowledge the metabolic core of the Colorado Clinical Nutrition Research Unit (National Institute of Diabetes and Digestive and Kidney Diseases Grant P30-DK-48520-01) for assistance with insulin measurements.


    FOOTNOTES

This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-47416 and DK-55386.

Address for reprint requests and other correspondence: J. S. Thresher, Dept. of Exercise Science and Physical Education, Physical Education East Bldg. Rm. 107B, Arizona State Univ., Tempe, AZ 85287-0404 (E-mail: jeffrey.thresher{at}asu.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 24 January 2000; accepted in final form 6 June 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Bergman, RN, Finegood DT, and Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 6: 45-86, 1985[ISI][Medline].

2.   Chan, TM, and Exton JH. A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal Biochem 71: 96-105, 1976[ISI][Medline].

3.   Debodo, RD, Steele R, Altszuler N, Dunn A, and Bishop JS. On the hormonal regulation of carbohydrate metabolism: studies with [14C]glucose. Recent Prog Horm Res 19: 445-448, 1963.

4.   Denton, RM, and Randle PJ. Concentrations of glycerides and phospholipids in rat heart and gastrocnemius muscles: effects of alloxan-diabetes and perfusion. Biochem J 104: 416-422, 1967[ISI][Medline].

5.   Finegood, DT, and Bergman RN. Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 37: 1025-1037, 1988[Abstract].

6.   Finegood, DT, Bergman RN, and Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 35: 914-924, 1987.

7.   Gannon, MC, and Nuttall FQ. Factors affecting interpretation of postprandial glucose and insulin areas. Diabetes Care 10: 759-763, 1987[Abstract].

8.   Hamman, RF. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 8: 287-338, 1992[ISI][Medline].

9.   Koyama, K, Chen G, Lee Y, and Unger RH. Tissue triglycerides, insulin resistance, and insulin production: implication for hyperinsulinemia of obesity. Am J Physiol Endocrinol Metab 273: E708-E713, 1997.

10.   Krssak, M, Petersen KF, Dresnar A, Dipietro L, Vogel SM, Rothman DL, Shulman GI, and Roden M. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42: 113-116, 1999[ISI][Medline].

11.   Lombardo, YB, Chicco A, D'Alessandro ME, Martinelli M, Soria A, and Gutman R. Dietary fish oil normalize dyslipidemia and glucose intolerance with unchanged insulin levels in rats fed a high sucrose diet. Biochim Biophys Acta 1299: 175-182, 1996[Medline].

12.   McArthur, MD, You D, Klapstein K, and Finegood DT. Glucose effectiveness is the major determinant of intravenous glucose tolerance in the rat. Am J Physiol Endocrinol Metab 276: E739-E746, 1999[Abstract/Free Full Text].

13.   Pagliassotti, MJ, and Prach P. Quantity of sucrose in the diet alters the tissue pattern and time course of insulin resistance in young rats. Am J Physiol Regulatory Integrative Comp Physiol 269: R641-R646, 1995[Abstract/Free Full Text].

14.   Pagliassotti, MJ, Prach P, Koppenhafer T, and Pan DA. Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats. Am J Physiol Regulatory Integrative Comp Physiol 271: R1319-R1326, 1996[Abstract/Free Full Text].

15.   Pagliassotti, MJ, Shahrokhi KA, and Moscarello M. Involvement of liver and skeletal muscle in sucrose-induced insulin resistance: dose-response studies. Am J Physiol Regulatory Integrative Comp Physiol 266: R1637-R1644, 1994[Abstract/Free Full Text].

16.   Podolin, DA, Gayles EC, Wei Y, Thresher JS, and Pagliassotti MJ. Menhaden oil prevents but does not reverse sucrose-induced insulin resistance. Am J Physiol Regulatory Integrative Comp Physiol 274: R840-R848, 1998[Abstract/Free Full Text].

17.   Popovic, V, and Popovic P. Permanent cannulation of aorta and vena cava in rats and ground squirrels. J Appl Physiol 15: 727-728, 1960[Free Full Text].

18.   Steele, R, Wall JS, Debodo RC, and Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15-24, 1956.

19.   Storlien, LH, Kraegen EW, Jenkins AB, and Chisholm D. Effects of sucrose vs. starch diets on in vivo insulin action, thermogenesis, and obesity in rats. Am J Clin Nutr 47: 420-427, 1988[Abstract/Free Full Text].

20.   Thorburn, AW, Storlien LH, Jenkins AB, Khouri S, and Kraegen EW. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 49: 1155-1163, 1989[Abstract/Free Full Text].

21.   Tobey, TA, Mondon CE, Zavaroni I, and Reaven GM. Mechanism of insulin resistance in fructose-fed rats. Metabolism 31: 608-612, 1982[ISI][Medline].

22.   Zar, JH. Biostatistical Analysis (2nd ed.). Englewood Cliffs, NJ: ; Prentice-Hall, 1984, p. 188-191.


Am J Physiol Regul Integr Comp Physiol 279(4):R1334-R1340
0363-6119/00 $5.00 Copyright © 2000 the American Physiological Society



This article has been cited by other articles:


Home page
J. Am. Coll. Nutr.Home page
L. Robert, A. Narcy, Y. Rayssiguier, A. Mazur, and C. Remesy
Lipid Metabolism and Antioxidant Status in Sucrose vs. Potato-Fed Rats
J. Am. Coll. Nutr., February 1, 2008; 27(1): 109 - 116.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K.-A. Le, D. Faeh, R. Stettler, M. Ith, R. Kreis, P. Vermathen, C. Boesch, E. Ravussin, and L. Tappy
A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans
Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1374 - 1379.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Wei and M. J. Pagliassotti
Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance
Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E926 - E933.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. J. Davidoff, M. M. Mason, M. B. Davidson, M. W. Carmody, K. K. Hintz, L. E. Wold, D. A. Podolin, and J. Ren
Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments
Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E718 - E724.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. K Fried and S. P Rao
Sugars, hypertriglyceridemia, and cardiovascular disease
Am. J. Clinical Nutrition, October 1, 2003; 78(4): 873S - 880.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Rousseau, C. Helies-Toussaint, D. Moreau, D. Raederstorff, and A. Grynberg
Dietary n-3 PUFAs affect the blood pressure rise and cardiac impairments in a hyperinsulinemia rat model in vivo
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1294 - H1302.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
J. Leonora, L. Tjaderhane, and J.-M. Tieche
Parotid Gland Function and Dentin Apposition in Rat Molars
J. Dent. Res., April 1, 2002; 81(4): 259 - 264.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Pagliassotti, J. Kang, J. S. Thresher, C. K. Sung, and M. E. Bizeau
Elevated basal PI 3-kinase activity and reduced insulin signaling in sucrose-induced hepatic insulin resistance
Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E170 - E176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. E. Bizeau, J. S. Thresher, and M. J. Pagliassotti
A high-sucrose diet increases gluconeogenic capacity in isolated periportal and perivenous rat hepatocytes
Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E695 - E702.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thresher, J. S.
Right arrow Articles by Pagliassotti, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thresher, J. S.
Right arrow Articles by Pagliassotti, M. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online